iSpecimen (ISPC) Stock: Buy, Sell, or Hold?
ISPC - iSpecimen Inc. Common Stock
$0.82
-0.02 (-1.89%)
▼
5d:
-10.91%
30d:
-34.64%
90d:
-59.35%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 16, 2026
22d
Get Alerted When ISPC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ISPC is down 10.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ISPC is down 10.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ISPC is currently trading at $0.82, which is considered oversold relative to its 30-day fair value range of $0.97 to $1.30.
Technical Outlook: Technically, ISPC is in a strong downtrend. Immediate support is located at $0.79, while resistance sits at $1.13.
Market Sentiment: ISPC scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.00 (+267.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ISPC is in a strong downtrend. Immediate support is located at $0.79, while resistance sits at $1.13.
Market Sentiment: ISPC scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.00 (+267.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.97 -
$1.30
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 267.2% below Wall St target ($3.00)
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.97 -
$1.30
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.79
Resistance Level
$1.13
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Wall Street Target
$3.00
(+267.2%)
Revenue Growth (YoY)
-78.7%
Share & Embed Analysis
Last updated: October 23, 2026 10:56 PM ET
Data refreshes hourly during market hours. Next update: 11:56 PM
Data refreshes hourly during market hours. Next update: 11:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ISPC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$202 | 67 BUY |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
28 analysts |
$691 | 48 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$404 | 54 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$244 | 45 HOLD |
